Physiology and pharmacology of the parietal cell
- PMID: 3048449
- DOI: 10.1016/s0950-3528(88)80004-6
Physiology and pharmacology of the parietal cell
Abstract
The parietal cells possess the unique capacity to produce large quantities of acid at a high concentration, and this is reflected in unique properties at the cellular level. The cells are comparatively large, and they are equipped with secretory canaliculi, a multitude of mitochondria, and cytoplasmic tubulovesicles. During secretion many of the tubulovesicles merge with the secretory canaliculi, which then expand. In the process H+, K+-ATPase is transferred from the tubulovesicular membrane to the secretory membrane. This enzyme catalyses the final step in the production of HCl. Parietal cell activity is regulated through receptors on the basolateral cell surfaces. In the isolated gland and in the isolated parietal-cell fractions, stimulation of receptors for histamine evokes higher secretion than receptor stimulation with cholinergic compounds or with gastrin. In these experimental models, specific inhibitors are required to block acid secretion; for example histamine H2-receptor antagonists will block histamine-induced secretion but will be inactive when secretion is evoked by gastrin or by cholinergic stimulation. These stimuli cause a more or less marked increase in the intracellular levels of Ca2+, which acts as a second messenger, leading to the activation of phosphokinases and, ultimately, to morphological transformation of the parietal cells and acid secretion. Another such intracellular messenger is cAMP, which is formed in response to histamine stimulation only; prostaglandins may prevent this process and block acid secretion. The final step in the production of acid requires K+ and Cl- channels in the secretory membrane and the H+, K+-ATPase-catalysed exchange of K+ for H+ across this membrane. This reaction consumes large amounts of energy and depends on the aerobic production of ATP by the parietal cells. Substituted benzimidazoles, such as omeprazole, accumulate in the acid compartments of the parietal cells and inhibit the H+, K+-ATPase, thereby blocking acid production.
Similar articles
-
Cell biology of gastric acid secretion.Baillieres Clin Gastroenterol. 1993 Mar;7(1):1-21. doi: 10.1016/0950-3528(93)90029-r. Baillieres Clin Gastroenterol. 1993. PMID: 8386569 Review.
-
Pharmacology of gastric acid inhibition.Baillieres Clin Gastroenterol. 1993 Mar;7(1):23-54. doi: 10.1016/0950-3528(93)90030-v. Baillieres Clin Gastroenterol. 1993. PMID: 8097411 Review.
-
The Physiology of the Gastric Parietal Cell.Physiol Rev. 2020 Apr 1;100(2):573-602. doi: 10.1152/physrev.00016.2019. Epub 2019 Oct 31. Physiol Rev. 2020. PMID: 31670611 Free PMC article. Review.
-
Regulation of receptors on parietal cells on acid secretion.Scand J Gastroenterol Suppl. 1988;146:22-33. doi: 10.3109/00365528809099127. Scand J Gastroenterol Suppl. 1988. PMID: 2906467 Review.
-
Cellular mechanisms of acid secretion.Clin Gastroenterol. 1984 May;13(2):309-26. Clin Gastroenterol. 1984. PMID: 6086185 Review.
Cited by
-
Clinical evaluation of twenty cases of heterotopic gastric mucosa of upper esophagus during five-year observation, using gastroscopy in combination with histopathological and microbiological analysis of biopsies.Contemp Oncol (Pozn). 2013;17(2):171-5. doi: 10.5114/wo.2013.34376. Epub 2013 Apr 29. Contemp Oncol (Pozn). 2013. PMID: 23788986 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous